Brent Meier
About Brent Meier
Brent Meier is the Director of Analytical Science and Technology, Biologics Separations and General Methods Lifecycle at Bristol-Myers Squibb in Devens, MA.
Current Position at Bristol-Myers Squibb
Brent Meier currently holds the position of Director, Analytical Science and Technology, Biologics Separations and General Methods Lifecycle at Bristol-Myers Squibb in Devens, MA. In this role, he is responsible for overseeing the analytical CMC strategy to advance monoclonal antibodies, Fc fusion proteins, and conjugate biopharmaceuticals throughout all phases of development, commercialization, and post-approval.
Past Roles at Bristol-Myers Squibb
Before his current position, Brent Meier served as Associate Director, Global Quality Analytics at Bristol-Myers Squibb from 2015 to 2019 in Devens, MA. Prior to that, he was a Principal Scientist from 2014 to 2015 in Seattle, WA, and a Senior Scientist from 2011 to 2014. His roles at Bristol-Myers Squibb involved leading analytical CMC teams, setting technical strategies, and managing global quality analytical methods lifecycle.
Early Career Experience
Brent Meier began his career at Amgen as a Scientist from 2003 to 2008, followed by a position as Senior Scientist at ZymoGenetics from 2008 to 2011. These positions helped establish his foundation in biopharmaceuticals, leading to his extensive experience in managing and delivering analytical technologies and data for bioprocess and formulation development.
Educational Background
Brent Meier earned his Ph.D. in Biochemistry from the University of Kentucky, graduating in 2002. He then completed a Postdoctoral Fellowship in Proteomics and Medicinal Chemistry at the University of Colorado Anschutz Medical Campus from 2002 to 2003. Prior to that, he received his B.S. in Biology from Gannon University in 1997.
Leadership and Technical Expertise
Brent Meier is recognized for his versatile leadership style and strong technical expertise. He has a solid understanding of global regulations and current Good Manufacturing Practices (cGMP) requirements. Known for his ability to work across various interfaces, he fosters collaborative approaches to advance programs and optimize resources. His experience includes leading and managing teams, setting technical strategies, and representing analytical functions in regulatory meetings.